ATE202148T1 - Verfahren zur entdeckung von liganden - Google Patents

Verfahren zur entdeckung von liganden

Info

Publication number: ATE202148T1
Authority: AT; Austria
Prior art keywords: ligands; target; discovering ligands; discovering; analogues
Prior art date: 1994-02-01

Application number

AT95907093T

Other languages

English (en)

Inventor

Edwin Mellor Southern

Kalim Ullah Mir

Stephen Charles Case-Green

Original Assignee

Oxford Gene Tech Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-01

Filing date

1995-02-01

Publication date

2001-06-15

1995-02-01 Application filed by Oxford Gene Tech Ltd filed Critical Oxford Gene Tech Ltd

2001-06-15 Application granted granted Critical

2001-06-15 Publication of ATE202148T1 publication Critical patent/ATE202148T1/de

Links

239000003446 ligand Substances 0.000 title abstract 4
108091034117 Oligonucleotide Proteins 0.000 abstract 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
230000003993 interaction Effects 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00427—Means for dispensing and evacuation of reagents using masks
- B01J2219/0043—Means for dispensing and evacuation of reagents using masks for direct application of reagents, e.g. through openings in a shutter
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/0059—Sequential processes
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Computational Biology (AREA)
Crystallography & Structural Chemistry (AREA)
Plant Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT95907093T 1994-02-01 1995-02-01 Verfahren zur entdeckung von liganden ATE202148T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9401833A GB9401833D0 (en)	1994-02-01	1994-02-01	Method for discovering ligands
PCT/GB1995/000209 WO1995021265A1 (en)	1994-02-01	1995-02-01	Methods for discovering ligands

Publications (1)

Publication Number	Publication Date
ATE202148T1 true ATE202148T1 (de)	2001-06-15

Family

ID=10749622

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95907093T ATE202148T1 (de)	1994-02-01	1995-02-01	Verfahren zur entdeckung von liganden

Country Status (7)

Country	Link
US (2)	US6080585A (de)
EP (1)	EP0742837B1 (de)
JP (1)	JPH09508791A (de)
AT (1)	ATE202148T1 (de)
DE (1)	DE69521298T2 (de)
GB (1)	GB9401833D0 (de)
WO (1)	WO1995021265A1 (de)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6156501A (en) *	1993-10-26	2000-12-05	Affymetrix, Inc.	Arrays of modified nucleic acid probes and methods of use
US7375198B2 (en)	1993-10-26	2008-05-20	Affymetrix, Inc.	Modified nucleic acid probes
NO314334B1 (no) *	1994-03-07	2003-03-10	Toennesen Svein Olav	Innstillbart feste for skulderstropper på en ryggsekk
US5663064A (en) *	1995-01-13	1997-09-02	University Of Vermont	Ribozymes with RNA protein binding site
US6458530B1 (en)	1996-04-04	2002-10-01	Affymetrix Inc.	Selecting tag nucleic acids
CA2255599C (en)	1996-04-25	2006-09-05	Bioarray Solutions, Llc	Light-controlled electrokinetic assembly of particles near surfaces
GB9620749D0 (en) *	1996-10-04	1996-11-20	Brax Genomics Ltd	Identifying antisense oligonucleotides
CA2289872C (en) *	1997-05-05	2007-07-31	Third Wave Technologies, Inc.	Target-dependent reactions using structure-bridging oligonucleotides
US6242246B1 (en) *	1997-12-15	2001-06-05	Somalogic, Inc.	Nucleic acid ligand diagnostic Biochip
US20060057573A1 (en)	2002-02-15	2006-03-16	Somalogic, Inc	Methods and reagents for detecting target binding by nucleic acid ligands
US20070166741A1 (en)	1998-12-14	2007-07-19	Somalogic, Incorporated	Multiplexed analyses of test samples
US6087102A (en)	1998-01-07	2000-07-11	Clontech Laboratories, Inc.	Polymeric arrays and methods for their use in binding assays
GB2335035B (en) *	1998-03-03	2003-05-28	Brax Genomics Ltd	Screening for functional antisense agents
US6979728B2 (en) *	1998-05-04	2005-12-27	Baylor College Of Medicine	Articles of manufacture and methods for array based analysis of biological molecules
US7244559B2 (en) *	1999-09-16	2007-07-17	454 Life Sciences Corporation	Method of sequencing a nucleic acid
US7211390B2 (en) *	1999-09-16	2007-05-01	454 Life Sciences Corporation	Method of sequencing a nucleic acid
DE60117556T2 (de)	2000-06-21	2006-11-02	Bioarray Solutions Ltd.	Multianalytische molekularanalyse durch verwendung anwendungsspezifischer zufallspartikelarrays
US9709559B2 (en)	2000-06-21	2017-07-18	Bioarray Solutions, Ltd.	Multianalyte molecular analysis using application-specific random particle arrays
US20020187482A1 (en) *	2000-09-25	2002-12-12	Zicai Liang	Methods and means of RNA analysis
WO2002038729A2 (en) *	2000-11-10	2002-05-16	Stratagene	GENE MONITORING AND GENE IDENTIFICATION USING cDNA ARRAYS
AU2002255478A1 (en) *	2001-01-10	2002-09-12	Pe Corporation (Ny)	Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
GB0105787D0 (en) *	2001-03-08	2001-04-25	Expresson Biosystems Ltd	Complex element micro-array and methods of use
GB0105789D0 (en) *	2001-03-08	2001-04-25	Expresson Biosystems Ltd	Detecting interactions between oligonucleotides and RNA using fluorescence resonance energy transfer (FRET)
GB0105790D0 (en) *	2001-03-08	2001-04-25	Expresson Biosystems Ltd	Detecting binding of mRNA to an oligonnucleotide array using RNA dependent nucleic acid modifying enzymes
EP2465943A3 (de)	2001-03-16	2012-10-03	Kalim Mir	Lineare Polymeranzeige
WO2002090599A1 (en)	2001-05-09	2002-11-14	Genetic Id, Inc.	Universal microarray system
DK2070939T3 (da)	2001-05-25	2014-06-23	Univ Duke	Modulatorer af farmakologiske midler
US20030027133A1 (en) *	2001-05-31	2003-02-06	Cawse James Norman	Method of improving a mixture experiment
US7262063B2 (en)	2001-06-21	2007-08-28	Bio Array Solutions, Ltd.	Directed assembly of functional heterostructures
WO2003004690A2 (en) *	2001-07-06	2003-01-16	454$m(3) CORPORATION	Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US7297553B2 (en) *	2002-05-28	2007-11-20	Nanosphere, Inc.	Method for attachment of silylated molecules to glass surfaces
AU2002322458A1 (en) *	2001-07-13	2003-01-29	Nanosphere, Inc.	Method for immobilizing molecules onto surfaces
US20030054396A1 (en) *	2001-09-07	2003-03-20	Weiner Michael P.	Enzymatic light amplification
CA2497740C (en)	2001-10-15	2011-06-21	Bioarray Solutions, Ltd.	Multiplexed analysis of polymorphic loci by probe elongation-mediated detection
US20080138800A1 (en) *	2001-10-15	2008-06-12	Alice Xiang Li	Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
US20050124022A1 (en) *	2001-10-30	2005-06-09	Maithreyan Srinivasan	Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en)	2001-10-30	2005-06-07	454 Corporation	Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6956114B2 (en)	2001-10-30	2005-10-18	'454 Corporation	Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6916621B2 (en) *	2002-03-27	2005-07-12	Spectral Genomics, Inc.	Methods for array-based comparitive binding assays
US7214492B1 (en)	2002-04-24	2007-05-08	The University Of North Carolina At Greensboro	Nucleic acid arrays to monitor water and other ecosystems
US9126165B1 (en)	2002-04-24	2015-09-08	The University Of North Carolina At Greensboro	Nucleic acid arrays to monitor water and other ecosystems
US8383342B2 (en)	2002-04-24	2013-02-26	The University Of North Carolina At Greensboro	Compositions, products, methods and systems to monitor water and other ecosystems
US8048623B1 (en)	2002-04-24	2011-11-01	The University Of North Carolina At Greensboro	Compositions, products, methods and systems to monitor water and other ecosystems
AU2003298655A1 (en)	2002-11-15	2004-06-15	Bioarray Solutions, Ltd.	Analysis, secure access to, and transmission of array images
US7575865B2 (en) *	2003-01-29	2009-08-18	454 Life Sciences Corporation	Methods of amplifying and sequencing nucleic acids
CA2513899C (en) *	2003-01-29	2013-03-26	454 Corporation	Methods of amplifying and sequencing nucleic acids
US20050233390A1 (en) *	2003-04-09	2005-10-20	Allen John W	Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor
US7927796B2 (en)	2003-09-18	2011-04-19	Bioarray Solutions, Ltd.	Number coding for identification of subtypes of coded types of solid phase carriers
CA2539824C (en)	2003-09-22	2015-02-03	Xinwen Wang	Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
CA2544041C (en)	2003-10-28	2015-12-08	Bioarray Solutions Ltd.	Optimization of gene expression analysis using immobilized capture probes
CA2544202C (en)	2003-10-29	2012-07-24	Bioarray Solutions Ltd.	Multiplexed nucleic acid analysis by fragmentation of double-stranded dna
EP2290073A3 (de)	2004-05-28	2011-08-31	Asuragen, Inc.	Verfahren und Zusammensetzungen mit MicroRNA
JP3916086B2 (ja) *	2004-06-29	2007-05-16	ソニー株式会社	ハイブリダイゼーションなどの相互作用を検出する方法及び検出部、該検出部を備えるバイオアッセイ用基板、ハイブリダイゼーションなどの相互作用を検出する装置、並びに試薬キット
US7848889B2 (en)	2004-08-02	2010-12-07	Bioarray Solutions, Ltd.	Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
EP2302055B1 (de)	2004-11-12	2014-08-27	Asuragen, Inc.	Verfahren und Zusammensetzungen, die miRNAs und miRNAa-inhibitorischen Molekülen verbunden sind
EP2604703B1 (de)	2005-03-14	2017-02-01	The Board of Trustees of the Leland Stanford Junior University	Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate
US8486629B2 (en)	2005-06-01	2013-07-16	Bioarray Solutions, Ltd.	Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
EP1731620A1 (de)	2005-06-07	2006-12-13	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Methode zur Diagnose von Immun-Transplantatstoleranz
EP2041574B1 (de)	2006-07-14	2016-11-16	The Regents of The University of California	Krebsbiomarker und anwendungsverfahren dafür
WO2008036776A2 (en)	2006-09-19	2008-03-27	Asuragen, Inc.	Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
US20090131348A1 (en)	2006-09-19	2009-05-21	Emmanuel Labourier	Micrornas differentially expressed in pancreatic diseases and uses thereof
US7855054B2 (en)	2007-01-16	2010-12-21	Somalogic, Inc.	Multiplexed analyses of test samples
US20110136099A1 (en)	2007-01-16	2011-06-09	Somalogic, Inc.	Multiplexed Analyses of Test Samples
AU2008210421B2 (en)	2007-01-30	2014-03-13	Pharmacyclics Llc	Methods for determining cancer resistance to histone deacetylase inhibitors
EP1961825A1 (de)	2007-02-26	2008-08-27	INSERM (Institut National de la Santé et de la Recherche Medicale)	Verfahren zur Vorhersage des Auftretens von Metastasen bei Brustkrebspatienten
US8906700B2 (en)	2007-11-06	2014-12-09	Ambergen, Inc.	Methods and compositions for phototransfer
WO2009097424A1 (en)	2008-01-29	2009-08-06	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Fstl-1 as a biomarker of inflammation
US8658379B2 (en)	2008-01-29	2014-02-25	University of Pittsburgh—of the Commonwealth System of Higher Education	Follistatin-like protein-1 as a biomarker for sepsis
WO2009137807A2 (en)	2008-05-08	2009-11-12	Asuragen, Inc.	Compositions and methods related to mirna modulation of neovascularization or angiogenesis
WO2010021696A1 (en)	2008-08-18	2010-02-25	The Board Of Trustees Of The Leland Stanford Junior University	Methods and compositions for determining a graft tolerant phenotype in a subject
DK2329259T3 (en)	2008-08-29	2016-05-09	Janssen Biotech Inc	MARKERS AND PROCEDURES FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISEASES USING A 20-GEN PANEL
US20120052066A1 (en)	2008-11-07	2012-03-01	Cesar Calderon	Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
PL2827150T3 (pl)	2009-08-22	2021-05-31	The Board Of Trustees Of The Leland Stanford Junior University	Obrazowanie i ocena zarodków, oocytów i komórek macierzystych
EP2507630B1 (de)	2009-12-02	2017-01-25	The Board of Trustees of The Leland Stanford Junior University	Biomarker zur bestimmung eines allotransplantattoleranten phänotyps
GB0922085D0 (en)	2009-12-17	2010-02-03	Cambridge Entpr Ltd	Cancer diagnosis and treatment
EP2542678B1 (de)	2010-03-04	2017-04-12	InteRNA Technologies B.V.	Mirna-molekül, das durch seine quelle definiert ist, und seine therapeutischen verwendungen bei emt assoziierten krebs
WO2011133539A2 (en)	2010-04-19	2011-10-27	The Procter & Gamble Company	Combined energy and topical composition application for regulating the condition of mammalian skin
MX2012012235A (es)	2010-04-19	2012-11-23	Procter & Gamble	Firmas geneticas y matrices geneticas asociadas con la administracion de corriente de radio frecuencia conducida electricamente a la piel y metodos y tratamiento relacionados a ellos.
US12571798B2 (en)	2010-04-27	2026-03-10	The Regents Of The University Of California	Cancer biomarkers and methods of use thereof
EP2591106A1 (de)	2010-07-06	2013-05-15	InteRNA Technologies B.V.	Mirna und ihre diagnostischen und therapeutischen verwendungen für mit melanomen assoziierte erkrankungen oder leiden oder für mit dem aktivierten braf-pfad assoziierte erkrankungen oder leiden
WO2012019099A2 (en)	2010-08-05	2012-02-09	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Follistatin-like-protein-1 as a biomarker for inflammatory disorders
EP2619574B1 (de)	2010-09-15	2020-10-28	Almac Diagnostic Services Limited	Molekulartest zur vorhersage der reaktion auf einen dns-schädigung wirkstoff von krebspatienten
BR112013012265A2 (pt)	2010-11-17	2016-08-02	Asuragen Inc	mirnas como biomarcadores para distinguir neoplasmas de tireoide benignos de malignos
EP2474617A1 (de)	2011-01-11	2012-07-11	InteRNA Technologies BV	MIR zur Behandlung von Neoangiogenese
CA2827945C (en)	2011-02-23	2021-10-12	The Board Of Trustees Of The Leland Stanford Junior University	Methods of detecting aneuploidy in human embryos
EP2681566A2 (de)	2011-02-28	2014-01-08	University of Iowa Research Foundation	Anti-müller-hormon-veränderungen in der schwangerschaft und vorhersage von schwangerschaftsnebenwirkungen und des geschlechts
US10260097B2 (en)	2011-06-02	2019-04-16	Almac Diagnostics Limited	Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
WO2013040251A2 (en)	2011-09-13	2013-03-21	Asurgen, Inc.	Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2013063519A1 (en)	2011-10-26	2013-05-02	Asuragen, Inc.	Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
WO2013063544A1 (en)	2011-10-27	2013-05-02	Asuragen, Inc.	Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
WO2013087789A1 (en)	2011-12-13	2013-06-20	Glykos Finland Ltd.	Antibody isoform arrays and methods thereof
WO2014007623A1 (en)	2012-07-03	2014-01-09	Interna Technologies B.V.	Diagnostic portfolio and its uses
WO2014055117A1 (en)	2012-10-04	2014-04-10	Asuragen, Inc.	Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
SG11201504023SA (en)	2012-12-03	2015-06-29	Almac Diagnostics Ltd	Molecular diagnostic test for cancer
US9758835B2 (en)	2013-03-15	2017-09-12	Baylor Research Institute	Ulcerative colitis (UC)-associated colorectal neoplasia markers
US9944992B2 (en)	2013-03-15	2018-04-17	The University Of Chicago	Methods and compositions related to T-cell activity
CA2907377A1 (en)	2013-03-15	2014-09-18	Baylor Research Institute	Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
GB201409479D0 (en)	2014-05-28	2014-07-09	Almac Diagnostics Ltd	Molecular diagnostic test for cancer
EP3194623B1 (de)	2014-08-12	2022-01-05	Wayne State University	Systeme und verfahren zur erkennung von stress von stammzellen und verwendungen davon
WO2016090323A1 (en)	2014-12-05	2016-06-09	Prelude, Inc.	Dcis recurrence and invasive breast cancer
GB201512869D0 (en)	2015-07-21	2015-09-02	Almac Diagnostics Ltd	Gene signature for minute therapies
US20190128895A1 (en)	2016-04-20	2019-05-02	Ldx Prognostics Limited Co.	Methods and compositions for prognosing preterm birth
CN109196362A (zh)	2016-05-17	2019-01-11	苏州爱尔迪思生物科技有限公司	用于提供子痫前期评估的方法和组合物
CN111566212A (zh)	2017-11-03	2020-08-21	因特尔纳技术有限公司	miRNA分子，等同物，安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生
WO2019104155A2 (en)	2017-11-22	2019-05-31	The University Of Chicago	Chemical probe-dependent evaluation of protein activity and uses thereof
US11957695B2 (en)	2018-04-26	2024-04-16	The Broad Institute, Inc.	Methods and compositions targeting glucocorticoid signaling for modulating immune responses
WO2019213660A2 (en)	2018-05-04	2019-11-07	The Broad Institute, Inc.	Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
WO2020036926A1 (en)	2018-08-17	2020-02-20	Cellecta, Inc.	Multiplex preparation of barcoded gene specific dna fragments
US20220187301A1 (en)	2018-09-14	2022-06-16	Prelude Corporation	Method of selection for treatment of subjects at risk of invasive breast cancer
US20220401460A1 (en)	2018-10-10	2022-12-22	Dana-Farber Cancer Institute, Inc.	Modulating resistance to bcl-2 inhibitors
US12402610B2 (en)	2018-11-09	2025-09-02	The Broad Institute, Inc.	Methods and compositions for modulating innate lymphoid cell pathogenic effectors
CA3131740A1 (en)	2019-02-27	2020-09-03	Madera Therapeutics, LLC	Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
US20220154282A1 (en)	2019-03-12	2022-05-19	The Broad Institute, Inc.	Detection means, compositions and methods for modulating synovial sarcoma cells
EP3937969A1 (de)	2019-03-14	2022-01-19	The Broad Institute, Inc.	Zusammensetzungen und verfahren zur modulation der cgrp-signalisierung zur regulierung der angeborenen lymphoiden darmzellen
US20220152148A1 (en)	2019-03-18	2022-05-19	The Broad Institute, Inc.	Modulation of type 2 immunity by targeting clec-2 signaling
EP3942023A1 (de)	2019-03-18	2022-01-26	The Broad Institute, Inc.	Zusammensetzungen und verfahren zur modulation metabolischer regulatoren der t-zell-pathogenität
EP3947727A4 (de)	2019-04-05	2023-01-04	Board of Regents, The University of Texas System	Verfahren und anwendungen zur zellen-barcodierung
JP7566775B2 (ja)	2019-04-12	2024-10-15	ザリージェンツオブザユニバーシティオブカリフォルニア	筋肉量及び酸化的代謝を増加させるための組成物及び方法
WO2021030627A1 (en)	2019-08-13	2021-02-18	The General Hospital Corporation	Methods for predicting outcomes of checkpoint inhibition and treatment thereof
US12421557B2 (en)	2019-08-16	2025-09-23	The Broad Institute, Inc.	Methods for predicting outcomes and treating colorectal cancer using a cell atlas
US11981922B2 (en)	2019-10-03	2024-05-14	Dana-Farber Cancer Institute, Inc.	Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
US12195725B2 (en)	2019-10-03	2025-01-14	Dana-Farber Cancer Institute, Inc.	Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity
US11793787B2 (en)	2019-10-07	2023-10-24	The Broad Institute, Inc.	Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
US11844800B2 (en)	2019-10-30	2023-12-19	Massachusetts Institute Of Technology	Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
WO2021127610A1 (en)	2019-12-20	2021-06-24	EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE	Cancer signatures, methods of generating cancer signatures, and uses thereof
US12165747B2 (en)	2020-01-23	2024-12-10	The Broad Institute, Inc.	Molecular spatial mapping of metastatic tumor microenvironment
EP4192486A4 (de)	2020-08-07	2024-05-01	The Broad Institute, Inc.	Therapeutisches targeting der phosphatdysregulation bei krebs über den xpr1:kids220-proteinkomplex
US20240150453A1 (en)	2021-03-09	2024-05-09	Massachusetts Institute Of Technology	Methods of predicting response to anti-tnf blockade in inflammatory bowel disease
WO2024028794A1 (en)	2022-08-02	2024-02-08	Temple Therapeutics BV	Methods for treating endometrial and ovarian hyperproliferative disorders
WO2024124044A1 (en)	2022-12-07	2024-06-13	The Brigham And Women’S Hospital, Inc.	Compositions and methods targeting sat1 for enhancing anti¬ tumor immunity during tumor progression
WO2024192141A1 (en)	2023-03-13	2024-09-19	Dana-Farber Cancer Institute, Inc.	Treatment of cancers having a drug-resistant mesenchymal cell state
WO2024226838A2 (en)	2023-04-25	2024-10-31	The Brigham And Women's Hospital, Inc.	Treatment of autoimmune diseases having a pathogenic t cell state
WO2025248505A1 (en)	2024-05-31	2025-12-04	Wayne State University	Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4563417A (en) *	1984-08-31	1986-01-07	Miles Laboratories, Inc.	Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4921788A (en) *	1988-04-12	1990-05-01	The Research Foundation Of State University Of New York	Competitive nucleic acid immunoassay for the detection of analytes
US5700637A (en) *	1988-05-03	1997-12-23	Isis Innovation Limited	Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5143854A (en) *	1989-06-07	1992-09-01	Affymax Technologies N.V.	Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
ES2259800T3 (es) *	1990-06-11	2006-10-16	Gilead Sciences, Inc.	Procedimientos de uso de ligandos de acido nucleico.
US5270163A (en) *	1990-06-11	1993-12-14	University Research Corporation	Methods for identifying nucleic acid ligands
US5474796A (en) *	1991-09-04	1995-12-12	Protogene Laboratories, Inc.	Method and apparatus for conducting an array of chemical reactions on a support surface
US5846708A (en) *	1991-11-19	1998-12-08	Massachusetts Institiute Of Technology	Optical and electrical methods and apparatus for molecule detection
US5412087A (en) *	1992-04-24	1995-05-02	Affymax Technologies N.V.	Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
CA2124087C (en) *	1991-11-22	2002-10-01	James L. Winkler	Combinatorial strategies for polymer synthesis
US5585275A (en) *	1992-09-02	1996-12-17	Arris Pharmaceutical Corporation	Pilot apparatus for peptide synthesis and screening
US5635385A (en) *	1993-09-15	1997-06-03	Temple University-Of The Commonwealth System Of Higher Education	Multi-unit ribozyme inhibition of oncogene gene expression
US5429807A (en) *	1993-10-28	1995-07-04	Beckman Instruments, Inc.	Method and apparatus for creating biopolymer arrays on a solid support surface

1994
- 1994-02-01 GB GB9401833A patent/GB9401833D0/en active Pending
1995
- 1995-02-01 AT AT95907093T patent/ATE202148T1/de not_active IP Right Cessation
- 1995-02-01 WO PCT/GB1995/000209 patent/WO1995021265A1/en not_active Ceased
- 1995-02-01 EP EP95907093A patent/EP0742837B1/de not_active Expired - Lifetime
- 1995-02-01 JP JP7520455A patent/JPH09508791A/ja not_active Ceased
- 1995-02-01 US US08/676,140 patent/US6080585A/en not_active Expired - Fee Related
- 1995-02-01 DE DE69521298T patent/DE69521298T2/de not_active Expired - Fee Related
2000
- 2000-04-26 US US09/559,402 patent/US20020031766A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0742837B1 (de)	2001-06-13
JPH09508791A (ja)	1997-09-09
DE69521298D1 (de)	2001-07-19
GB9401833D0 (en)	1994-03-30
US20020031766A1 (en)	2002-03-14
DE69521298T2 (de)	2002-05-08
US6080585A (en)	2000-06-27
WO1995021265A1 (en)	1995-08-10
EP0742837A1 (de)	1996-11-20

Legal Events

Date	Code	Title	Description
2001-08-15	UEP	Publication of translation of european patent specification
2003-11-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69521298D1 (de)	2001-07-19	Verfahren zur entdeckung von liganden
DE50015005D1 (de)	2008-04-17	Verfahren zur katalytischen Durchführung von Hydroformylierungen
DE69822348D1 (de)	2004-04-15	R. b. yun s verfahren zur ausbeutung von tagebaulagerstätten
ATE428780T1 (de)	2009-05-15	Verfahren zur zubereitung von antisense oligonukleotiden
DE3578190D1 (de)	1990-07-19	Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.
DE69003513D1 (de)	1993-10-28	Verfahren zur Bohrlochkomplettierung.
DE69621141D1 (de)	2002-06-13	Prozess zur entschwefelung von benzin
DE59603145D1 (de)	1999-10-28	Vorrichtung zur Zugabe von Reinigungsmitteln, insbesondere für Geschirrspülmaschinen
DE69938766D1 (de)	2008-07-03	Verfahren zur Rückgewinnung von Substratscheiben
DE69509332D1 (de)	1999-06-02	Geschoss für die Zerstörung von harten Zielen, die tief vergraben sind
DE69824832D1 (de)	2004-08-05	Verfahren zur verbesserung der transformationseffizienz.
DE3672197D1 (de)	1990-08-02	Verfahren zur absetzung von in der umwelt bestaendigen organischen verbindungen.
DE3780593D1 (de)	1992-08-27	Verfahren zur verhinderung von ablagerungen.
DE69000118D1 (de)	1992-07-09	Verfahren zur regenerierung von katalysatoren.
DE69109868D1 (de)	1995-06-22	Verfahren zur bestimmung von dns-sequenzen.
DE69919304D1 (de)	2004-09-16	Verfahren zur Konditionierung von organischen Pigmenten
DE69731112D1 (de)	2004-11-11	Verfahren zur synthese von phosphorothioat-oligonukelotiden
ATE374368T1 (de)	2007-10-15	Oberfläche zur immobilisierung von liganden
DE69710598D1 (de)	2002-03-28	Verfahren zur Herstellung von plattiertem Stahlblech
EP1140978A4 (de)	2006-03-01	Methoden zur identifizierung von antigen-gensequenzen
DE69114564D1 (de)	1995-12-21	Verfahren zur Härtung von Methylhydrogensiloxanen.
DE69807148D1 (de)	2002-09-19	Verfahren zur Hydroformylierung von Olefininen
DE69811677D1 (de)	2003-04-03	Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.
DE69942542D1 (de)	2010-08-12	Verfahren zur produktion von l-ribose.
DE69001160D1 (de)	1993-04-29	Verfahren zur methanolspaltung.